Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bausch Health Companies Inc. (BHC)

8.1   0.39 (5.06%) 03-31 16:00
Open: 7.715 Pre. Close: 7.71
High: 8.11 Low: 7.715
Volume: 3,733,048 Market Cap: 2,932(M)

Technical analysis

as of: 2023-03-31 4:17:06 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 10.06     One year: 11.22
Support: Support1: 7.01    Support2: 5.84
Resistance: Resistance1: 8.62    Resistance2: 9.6
Pivot: 7.66
Moving Average: MA(5): 7.67     MA(20): 7.86
MA(100): 7.67     MA(250): 8.72
MACD: MACD(12,26): -0.2     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 61.6     %D(3): 44
RSI: RSI(14): 52.9
52-week: High: 23.64  Low: 4
Average Vol(K): 3-Month: 5,054 (K)  10-Days: 2,296 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BHC ] has closed below upper band by 4.2%. Bollinger Bands are 48.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.82 - 7.85 7.85 - 7.87
Low: 7.47 - 7.51 7.51 - 7.54
Close: 7.65 - 7.7 7.7 - 7.75

Company Description

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Headline News

Fri, 31 Mar 2023
Bausch Health Cos. Inc. stock rises Friday, outperforms market - MarketWatch

Thu, 30 Mar 2023
Shareholders may not want to ignore the US$708k worth sales made by Bausch Health Companies Inc. (NYSE:BHC) insiders this past year - Simply Wall St

Thu, 16 Mar 2023
BHC May 19th Options Begin Trading - Nasdaq

Tue, 14 Mar 2023
Bausch Health Companies Inc. (NYSE:BHC) Short Interest Update - MarketBeat

Fri, 10 Mar 2023
Academy Capital Management Inc. TX Sells 433734 Shares of ... - MarketBeat

Thu, 02 Mar 2023
Bausch Health Cos. Inc. stock rises Thursday, outperforms market - MarketWatch

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 362 (M)
Shares Float 286 (M)
% Held by Insiders 3.3 (%)
% Held by Institutions 81.5 (%)
Shares Short 27,480 (K)
Shares Short P.Month 24,000 (K)

Stock Financials

EPS -0.61
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.91
Profit Margin (%) -2.8
Operating Margin (%) 18.2
Return on Assets (ttm) 3.3
Return on Equity (ttm) -187.7
Qtrly Rev. Growth -0.2
Gross Profit (p.s.) 15.9
Sales Per Share 22.42
EBITDA (p.s.) 7.95
Qtrly Earnings Growth 0
Operating Cash Flow -728 (M)
Levered Free Cash Flow 1,020 (M)

Stock Valuations

PE Ratio -13.5
PEG Ratio 0.8
Price to Book value -4.25
Price to Sales 0.36
Price to Cash Flow -4.03

Stock Dividends

Dividend 1
Forward Dividend 0
Dividend Yield 12.3%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2010-11-09
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.